Skip to content
10-K

Annual Report

ORCHARD THERAPEUTICS PLC

0000950170-23-007708

← back to feed
Filed
Mar 14, 2023 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 10, 2023 183.98M sh
Shares Diluted FY 2022 · Dec 31, 2022 127.98M sh
Shares Diluted FY 2022 · Dec 31, 2021 123.96M sh
Capex FY 2022 · Dec 31, 2022 $6.51M
Capex FY 2022 · Dec 31, 2021 $2.35M
Operating Cash Flow FY 2022 · Dec 31, 2022 −$75.99M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$125.1M
Long Term Debt FY 2022 · Dec 31, 2022 $22.99M
Long Term Debt FY 2022 · Dec 31, 2021 $32.09M
Short Term Debt FY 2022 · Dec 31, 2022 $9.43M
Cash And Equivalents FY 2022 · Dec 31, 2022 $68.42M
Cash And Equivalents FY 2022 · Dec 31, 2021 $55.91M
Stockholders Equity FY 2022 · Dec 31, 2022 $98.26M
Stockholders Equity FY 2022 · Dec 31, 2021 $209.95M
Stockholders Equity FY 2022 · Dec 31, 2020 $178.43M
Current Liabilities FY 2022 · Dec 31, 2022 $60.57M
Current Liabilities FY 2022 · Dec 31, 2021 $42.79M
Total Liabilities FY 2022 · Dec 31, 2022 $120.64M
Total Liabilities FY 2022 · Dec 31, 2021 $112.46M
Current Assets FY 2022 · Dec 31, 2022 $168.15M
Current Assets FY 2022 · Dec 31, 2021 $275.32M
Total Assets FY 2022 · Dec 31, 2022 $218.91M
Total Assets FY 2022 · Dec 31, 2021 $322.41M
Eps Diluted FY 2022 · Dec 31, 2022 −$1.18
Eps Diluted FY 2022 · Dec 31, 2021 −$1.17
Eps Basic FY 2022 · Dec 31, 2022 −$1.18
Eps Basic FY 2022 · Dec 31, 2021 −$1.17
Sga Expense FY 2022 · Dec 31, 2022 $49.13M
Sga Expense FY 2022 · Dec 31, 2021 $54.91M
Rd Expense FY 2022 · Dec 31, 2022 $93.85M
Rd Expense FY 2022 · Dec 31, 2021 $86.98M
Net Income FY 2022 · Dec 31, 2022 −$150.66M
Net Income FY 2022 · Dec 31, 2021 −$144.58M
Operating Income FY 2022 · Dec 31, 2022 −$127.09M
Operating Income FY 2022 · Dec 31, 2021 −$140.43M
Cost Of Revenue FY 2022 · Dec 31, 2022 $6.77M
Cost Of Revenue FY 2022 · Dec 31, 2021 $226K
Revenue FY 2022 · Dec 31, 2022 $22.66M
Revenue FY 2022 · Dec 31, 2021 $1.68M